Linked Life Data

16146617

Source:http://linkedlifedata.com/resource/pubmed/id/16146617

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-9-8
pubmed:abstractText
Doxycycline hyclate 20 mg bid is an effective maintenance dosage in patients with inflammatory acne. Twelve subjects aged 14 to 36, both men and women, completed a 16-week study to demonstrate the effectiveness of submicrobial dosing of doxycycline hyclate. Seventeen subjects were screened, and three withdrew before receiving any medication. The subjects received doxycycline hyclate 100 mg daily for eight weeks. One subject withdrew due to unrelated side effects. Eleven subjects had a 50% reduction of lesions at eight weeks, which qualified them to enter the second eight-week phase of the study. This group received either doxycycline hyclate 20 mg bid or placebo. The six subjects receiving doxycycline hyclate 20 mg bid maintained their improvement, while the placebo group did not.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1330-027X
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
156-9
pubmed:dateRevised
2011-9-13
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
The treatment of acne vulgaris with low dosage doxycycline.
pubmed:affiliation
Department of Dermatology and Cutaneous Biology, Jefferson Medical College of Thomas Jefferson University, USA. Larryderm@yahoo.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't